Biotech Startups

Peerbridge Health develops solutions focused on cardiac care and clinical insight.

1 investor

PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.

1 investor

Pelagen engineers animal-free leather by cultivating skin tissue from cells, aiming to match the quality of conventional leather without the environmental or animal-welfare impact. Its biofabricated material targets applications in fashion, automotive, and interiors.

1 investor

Pelagos Pharma develops drugs targeting hard-to-treat receptors for age-related diseases, with a focus on extending healthspan and longevity.

1 investor

PeleMed (펠레메드) is a biotech company developing precision oncology therapeutics, including small-molecule inhibitors such as a next-generation FLT3 inhibitor for acute myeloid leukemia (AML) and a YAP-TEAD inhibitor. The company runs preclinical and clinical-stage drug development programs, with an FDA IND-approved Phase 1 trial for its FLT3 inhibitor.

1 investor

Pelton Shepherd provides cold chain packaging solutions and refrigerant expertise to customers requiring temperature-controlled supply logistics. The company operates as a third-generation family business with over 70 years of industry experience.

1 investor

Pending AI develops a drug discovery and development platform using quantum mechanics and artificial intelligence to enable pharmaceutical companies to develop medicines for any disease. The company serves pharmaceutical partners in asset co-development.

1 investor

Pentalink develops a fully automated sericulture system to produce silk fiber as a sustainable natural alternative to petroleum-based synthetic textiles. The company aims to revolutionize silk production through technological innovation in cultivation and processing.

1 investor

LEO Pharma is a global pharmaceutical company specializing in medical dermatology treatments for skin diseases, with additional focus on critical care including thrombosis and immunooncology. The company serves over 100 million patients annually across 70+ countries and employs 4,000 people.

1 investor

Peptido manufactures pharmaceutical active ingredients (APIs) in Germany, supplying customers with these substances for use in medicines. The company emphasizes quality control, regulatory registration for worldwide API markets, and sustainable production.

1 investor

Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.

1 investor

1 investor

Perception Biosystems develops automated, robotics-driven manufacturing systems for gene therapy, aiming to produce gene therapies for human clinical trials faster and more cheaply than conventional facilities. The company operates a robotic lab in the SF Bay Area and targets rare disease applications.

1 investor

Performance BioFilaments developed and produced nanofibrillated cellulose (NFC) materials. The company has ceased operations as of February 1, 2026.

1 investor

Performance Plants Inc. (PPI) is an agricultural biotechnology developer that conducts gene discovery and trait development to improve crop yield, drought tolerance, and heat tolerance without introducing foreign genes. Its technologies target staple food crops and biofuel crops to help farmers adapt to climate change, developed at its R&D lab in Kingston, Ontario, Canada.

1 investor

PerFormS is an innovative startup spun out of the Department of Life Sciences at the University of Modena and Reggio Emilia that develops health products using advanced formulation and nanotechnology to improve the bioavailability of active molecules. Its first patented technology targets an endogenous anti-inflammatory molecule for patients with acute or chronic skin inflammation such as psoriasis, positioned as an alternative to cortisone.

1 investor

Perlara is a biotech company that runs early-stage drug R&D programs for rare diseases, partnering with patient families, companies and impact investors to screen gene-edited patient avatars for repurposable drugs. It has launched drug repurposing trials at Mayo Clinic for rare conditions such as PMM2-CDG and NGLY1-CDDG.

1 investor

GigaCrop develops agricultural biotechnology to improve photosynthesis in crop plants through enzyme engineering, enabling more sustainable and efficient food and materials production. The company focuses initially on major crops like corn and soybean, with plans to expand to plants for biomanufacturing.

1 investor

PERME is a deep-tech home-testing platform that converts biological samples into digital health information in real time using an affordable device that does not require a lab, then applies data analytics and AI/ML to generate personalized health recommendations and telehealth consultations. Operating a B2B2C model, it serves individuals and partners with corporations for anonymized user-data analytics in the healthcare and wellness sectors, with labs in the United States and Israel.

1 investor

Permeasis Therapeutics is developing a Membrane Translocation Domain (MTD) platform that enables intracellular delivery of proteins and other large therapeutic macromolecules to the cytosol and intracellular compartments. The company initially targets genetically defined diseases where delivering functional proteins inside cells could have therapeutic impact.

1 investor

1 investor

PERSEO Biotechnology develops industrial processes that convert organic waste and byproducts into advanced bioethanol, bioproducts, and bioenergy using its own technology. It offers custom waste valorization projects, including industrial plants and innovation services, based on circular economy and sustainability principles.

1 investor

Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.

1 investor

Perseus SENOLYTIX is a gerotherapeutics company developing senolytic peptides to target senescent cells and restore cellular balance in aging organisms. The company focuses on translating scientific discoveries into therapeutics addressing fundamental mechanisms of aging.

1 investor